Jagsonpal Pharmaceuticals Limited (BOM:507789)

Jagsonpal Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,592	112.15	127.6	110.53	225.26	589.43
Short-Term Investments	-	1,175	1,352	1,036	245.31	-
Trading Asset Securities	-	-	-	-	-	32.51
Cash & Short-Term Investments	1,592	1,287	1,479	1,146	470.57	621.94
Cash Growth	104.56%	-12.98%	29.06%	143.59%	-24.34%	56.21%
Accounts Receivable	225.66	131.76	109.51	208.72	155.77	126.64
Other Receivables	-	-	-	-	-	15.37
Receivables	225.66	131.76	109.51	208.72	155.77	142.01
Inventory	158.47	152	149.97	206.76	297.42	297.25
Prepaid Expenses	-	16.62	16.02	10.68	10.62	-
Other Current Assets	41.37	24.24	212.95	73.17	156.43	143.58
Total Current Assets	2,018	1,612	1,968	1,646	1,091	1,205
Property, Plant & Equipment	81.86	88.37	93.02	242.78	225.73	233.47
Long-Term Investments	17.49	168.62	47	33.84	290.55	120.58
Goodwill	96.93	96.93	-	-	0.3	0.3
Other Intangible Assets	720.83	759.24	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	23.45
Other Long-Term Assets	55.25	57.5	62.97	27.25	34.86	59.45
Total Assets	2,990	2,783	2,171	1,949	1,642	1,642
Accounts Payable	129.7	97.34	75.96	165.8	185.5	180.5
Accrued Expenses	-	101.99	74.19	88.86	79.86	89.37
Short-Term Debt	-	-	-	-	-	67.88
Current Portion of Leases	16.47	16.07	13.84	7.54	-	-
Current Income Taxes Payable	15.69	-	-	0.19	2.33	38.22
Current Unearned Revenue	-	9.1	12.94	6.12	-	-
Other Current Liabilities	170.82	34.54	14.35	7.2	2.03	28
Total Current Liabilities	332.68	259.04	191.28	275.71	269.72	403.97
Long-Term Leases	71.89	76.32	75.57	52.47	-	-
Pension & Post-Retirement Benefits	-	-	-	-	-	0.18
Long-Term Deferred Tax Liabilities	40.42	30.7	20.73	21.63	32.38	18.59
Other Long-Term Liabilities	16.89	17.04	9.18	10.75	12.56	-
Total Liabilities	461.88	383.1	296.76	360.56	314.66	422.73
Common Stock	133.27	132.8	132.19	130.99	130.99	130.99
Additional Paid-In Capital	-	140.56	111.2	6	6	6
Retained Earnings	-	1,906	1,460	1,363	1,112	1,004
Comprehensive Income & Other	2,395	219.65	170.7	88.52	78.87	78.39
Shareholders' Equity	2,528	2,400	1,874	1,589	1,328	1,219
Total Liabilities & Equity	2,990	2,783	2,171	1,949	1,642	1,642
Total Debt	88.36	92.39	89.41	60.01	-	67.88
Net Cash (Debt)	1,504	1,195	1,390	1,086	470.57	554.06
Net Cash Growth	121.08%	-14.03%	27.96%	130.84%	-15.07%	65.84%
Net Cash Per Share	22.29	17.75	20.96	16.59	7.18	8.46
Filing Date Shares Outstanding	66.88	66.4	66.09	65.5	65.5	65.5
Total Common Shares Outstanding	66.88	66.4	66.09	65.5	65.5	65.5
Working Capital	1,685	1,353	1,777	1,370	821.09	800.8
Book Value Per Share	37.80	36.14	28.35	24.26	20.27	18.62
Tangible Book Value	1,711	1,543	1,874	1,589	1,327	1,219
Tangible Book Value Per Share	25.58	23.24	28.35	24.26	20.27	18.61
Land	-	-	-	87.59	87.59	87.59
Buildings	-	-	-	163.8	163.8	160.87
Machinery	-	14.77	20.38	18.02	329.61	328.99

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.